Literature DB >> 22171231

Giant renal angiomyolipoma.

Guru P Painuly1, Sanjay Goyal, Sanjana Nautiyal.   

Abstract

A 65-year-old woman from a rural area presented to the surgical service with a very large abdominal lump that the patient had first noticed 8 years previously. The lump had steadily increased in size over time, and the patient had dysuria, weakness and dyspnoea on exertion. On examination she was grossly anaemic with a large retroperitoneal lump that occupied the whole right side of abdomen; the lump was soft to firm in consistency and non-tender. She had no lymphoedema or other palpable lymph nodes. Ultrasound revealed a large retroperitoneal tumour with fatty elements, arising from the right kidney. There was no involvement of the intestines. Findings of the computed tomography scan were typical for renal angiomyolipoma. The patient underwent surgery and the tumour was excised. Four units of blood were transfused preoperatively and in addition two units were given postoperatively. The patient was given thromboprophylaxis perioperatively and in the postoperative period because she was bedridden and could not ambulate. She made an uneventful recovery.

Entities:  

Year:  2009        PMID: 22171231      PMCID: PMC3027913          DOI: 10.1136/bcr.04.2009.1747

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  30 in total

1.  Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms.

Authors:  Raouf M Seyam; Nabil K Bissada; Said A Kattan; Alaa A Mokhtar; Muhammad Aslam; Wahib E Fahmy; Walid A Mourad; Ali A Binmahfouz; Hassan M Alzahrani; Kamal A Hanash
Journal:  Urology       Date:  2008-09-21       Impact factor: 2.649

2.  Laparoscopic cryoablation of renal angiomyolipoma.

Authors:  Gregory F Byrd; Eric J Lawatsch; Hrair-George Mesrobian; Frank Begun; Peter Langenstroer
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

3.  Renal angiomyolipoma--experience of 20 years in Taiwan.

Authors:  S S Chen; A T Lin; K K Chen; L S Chang
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

4.  Renal angiomyolipoma: long-term results after arterial embolization.

Authors:  Nishita Kothary; Michael C Soulen; Timothy W I Clark; A J Wein; Richard D Shlansky-Goldberg; Peter B Crino; S William Stavropoulos
Journal:  J Vasc Interv Radiol       Date:  2005-01       Impact factor: 3.464

5.  The role of partial nephrectomy for the management of sporadic renal angiomyolipoma.

Authors:  Stephen A Boorjian; Igor Frank; Brant Inman; Christine M Lohse; John C Cheville; Bradley C Leibovich; Michael L Blute
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

6.  Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated.

Authors:  Prasanna Sooriakumaran; Philippa Gibbs; Geoffrey Coughlin; Virginia Attard; Frances Elmslie; Christopher Kingswood; Jeremy Taylor; Cathy Corbishley; Uday Patel; Christopher Anderson
Journal:  BJU Int       Date:  2009-06-02       Impact factor: 5.588

7.  Conservative management of giant symptomatic angiomyolipomas in patients with the tuberous sclerosis complex.

Authors:  Teresa L Danforth; Brian R Lane; Andrew C Novick
Journal:  BJU Int       Date:  2007-06-21       Impact factor: 5.588

8.  Renal angiomyolipoma: long-term results following selective arterial embolization.

Authors:  Jacob Ramon; Uri Rimon; Alex Garniek; Gil Golan; Paul Bensaid; Noam D Kitrey; Andrei Nadu; Zohar A Dotan
Journal:  Eur Urol       Date:  2008-04-18       Impact factor: 20.096

9.  Renal angiomyolipoma with lymph node involvement: a case report and literature review.

Authors:  Wei-Yu Lin; Cheng-Keng Chuang; Kwai-Fong Ng; Shuen-Kuei Liao
Journal:  Chang Gung Med J       Date:  2003-08

Review 10.  Malignant renal epithelioid angiomyolipoma with aggressive behavior and distant metastasis.

Authors:  Wen-Chiung Lin; Jia-Hwia Wang; Chao-Jung Wei; Chin-Chen Pan; Cheng-Yen Chang
Journal:  J Chin Med Assoc       Date:  2003-05       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.